Abstract
Purified human central nervous system myelin contains an endogenous cysteine protease which degrades the 100-kDa myelin-associated glycoprotein into a slightly smaller 90-kDa derivative called dMAG, and which has been implicated in demyelinating diseases. The native proteolytic site in human MAG was determined in order to characterize this cysteine protease in humans further. This was accomplished by identifying the carboxy-terminus of purified dMAG. The results of these experiments, in conjunction with peptidolysis assays of myelin, demonstrated that the enzyme which proteolyses MAG is extracellular and has cathepsin L-like specificity. Furthermore, it was shown that this cathepsin L-like activity potentially was regulated by the endogenous extracellular inhibitor cystatin C.
Similar content being viewed by others
REFERENCES
Quarles, R. H. 1997. Glycoproteins of myelin sheaths. J. Mol. Neurosci. 8:1–12.
Montag, D., Giese, K. P., Bartsch, U., Martini, R., Lang, Y., Bluthmann, H., Karthigasan, J., Kirschner, D. A., Wintergerst, E. S., Nave, K-A., Zielasek, J., Toyka, K. V., Lipp, H-P., and Schachner, M. 1994. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 13:229–46.
Li, C., Tropak, M. B., Gerlai, R., Clapoff, S., Abramow-Newerly, W., Trapp, B., Peterson, A., and Roder, J. 1994. Myelination in the absence of myelin-associated glycoprotein. Nature. 369:47–50.
Lassmann, H., Bartsch, U., Montag, D., and Schachner, M. 1997. Dying-back oligodendrogliopathy: a late sequel of myelin-associated glycoprotein deficiency. Glia 19:104–10.
Fruttiger, M., Montag, D., Schachner, M., and Martini, R. 1995. Crucial role for the myelin-associated glycoprotein in the maintenance of axon-myelin integrity. Eur. J. Neurosci. 7:511–5.
Sato, S., Yanagisawa, K., and Miyatake, T. 1984. Conversion of myelin-associated glycoprotein (MAG) to a smaller derivative by calcium activated neutral protease (CANP)-like enzyme in myelin and inhibition by E-64 analogue. Neurochem. Res. 9:629–35.
Sato, S., Quarles, R. H., and Brady, R. O. 1982. Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain. J. Neurochem. 39:97–105.
Yanagisawa, K., Quarles, R. H., Johnson, D., Brady, R. O., and Whitaker, J. N. 1985. A derivative of myelin-associated glycoprotein in cerebrospinal fluid of normal subjects and patients with neurological disease. Ann. Neurol. 18:464–9.
Gendelman, H. E., Pezeshkpour, G. H., Pressman, N. J., Wolinsky, J. S., Quarles, R. H., Dobersen, M. J., Trapp, B. D., Kitt, C. A., Aksamit, A., and Johnson, R. T. 1985. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases. Ann. Neurol. 18:324–8.
Itoyama, Y., Sternberger, N. H., Webster, H. D., Quarles, R. H., Cohen, S. R., and Richardson, E. P., Jr. 1980. Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions. Ann. Neurol. 7:167–77.
Prineas, J. W., Kwon, E. E., Sternberger, N. H., and Lennon, V. A. 1984. The distribution of myelin-associated glycoprotein and myelin basic protein in actively demyelinating multiple sclerosis lesions. J. Neuroimmunol. 6:251–64.
Johnson, D., Sato, S., Quarles, R. H., Inuzuka, T., Brady, R. O., and Tourtellotte, W. W. 1986. Quantitation of the myelin-associated glycoprotein in human nervous tissue from controls and multiple sclerosis patients. J. Neurochem. 46:1086–93.
Moller, J. R., Yanagisawa, K., Brady, R. O., Tourtellotte, W. W., and Quarles, R. H. 1987. Myelin-associated glycoprotein in multiple sclerosis lesions: a quantitative and qualitative analysis. Ann. Neurol. 22:469–74.
Moller, J. R. 1996. Rapid conversion of myelin-associated glycoprotein to a soluble derivative in primates. Brain Res. 741:27–31.
Stebbins, J. W., Jaffe, H., Fales, H. M., and Moller, J. R. 1997. Determination of a native proteolytic site in myelin-associated glycoprotein. Biochemistry 36:2221–6.
Berger, A., and Schechter, I. 1970. Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 257:249–64.
Norton, W. T., and Poduslo, S. E. 1973. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21:749–57.
Stone, K. L., and Williams, K. R. 1993. Enzymatic digestion of proteins and HPLC peptide isolation. Pages 43–69 in Matsudaira, P. (ed.), A practical guide to protein and peptide purification for microsequencing, Academic Press, Sandiego.
Stoney, K., and Nugent, K. 1995. Online preparation of complex biological samples prior to analysis by HPLC, LC/MS and/or protein sequencing. Pages 277–284 in Crabb, J. W. (ed.), Techniques in Protein Chemistry, Academic Press, San Diego.
Barrett, A. J. 1972. A new assay for cathepsin B1 and other thiol proteinases. Anal. Biochem. 47:280–93.
Kirschke, H., and Wiederanders, B. 1994. Cathepsin S and related lysosomal endopeptidases. Methods Enzymol. 244:500–11.
Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–54.
Eng, J. K., McCormack, A. L., and Yates, J. R. 1994. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass. Spectrom. 5:976–989.
Barrett, A. J., and Kirschke, H. 1981. Cathepsin B, Cathepsin H, and cathepsin L. Methods Enzymol. 80:535–61.
Kirschke, H., and Barrett, A. J. 1985. Cathepsin L—a lysosomal cysteine proteinase. Prog. Clin. Biol. Res. 180:61–9.
Banik, N. L., Chakrabarti, A., and Hogan, E. L. 1992. Calcium-Activated Neutral Protease in Myelin: its Role and Function. Pages 571–598 in Martenson, R. E. (ed.), Myelin: Biology and Chemistry, CRC Press, Boca Raton.
Marks, N., and Berg, M. J. 1987. Rat brain cathepsin L: characterization and differentiation from cathepsin B utilizing opioid peptides. Arch. Biochem. Biophys. 259:131–43.
Sasaki, T., Kikuchi, T., Yumoto, N., Yoshimura, N., and Murachi, T. 1984. Comparative specificity and kinetic studies on porcine calpain I and calpain II with naturally occurring peptides and synthetic fluorogenic substrates. J. Biol. Chem. 259:12489–94.
Goll, D. E., Kleese, W. C., Okitani, A., Kumamoto, T., Cong, J., and Kapprell, H. 1990. Historical background and current status of the Ca+2–dependent proteinase system. Pages 3–24 in Mellgren, R. L. and Murachi, T. (eds.), Intracellular Calcium-Dependent Proteolysis, CRC Press, Inc., Boca Raton.
Dehrmann, F. M., Coetzer, T. H., Pike, R. N., and Dennison, C. 1995. Mature cathepsin L is substantially active in the ionic milieu of the extracellular medium. Arch. Biochem. Biophys. 324:93–8.
Tu, G. F., Aldred, R. A., Southwell, B. R., and Schreiber, G. 1992. Strong conservation of the expression of cystatin C gene in choroid plexus. Am. Phys. J 32:R195–R200.
Trapp, B. D. 1988. Distribution of the myelin-associated glycoprotein and P0 protein during myelin compaction in quaking mouse peripheral nerve. J. Cell. Biol. 107:675–85.
Berlet, H. H. 1992. Degradation of myelin proteins by proteinases. Pages 599–631 in Martenson, R. E. (ed.), Myelin: Biology and Chemistry, CRC Press, Boca Raton.
Bollengier, F. 1987. Cystatin C, alias post-gamma-globulin: a marker for multiple sclerosis? J. Clin. Chem. Clin. Biochem. 25:589–93.
Sato, S., Fujita, N., Kurihara, T., Kuwano, R., Sakimura, K., Takahashi, Y., and Miyatake, T. 1989. cDNA cloning and amino acid sequence for human myelin-associated glycoprotein. Biochem. Biophys. Res. Commun. 163:1473–80.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stebbins, J.W., Jaffe, H. & Möller, J.R. Characterization of Myelin-Associated Glycoprotein (MAG) Proteolysis in the Human Central Nervous System. Neurochem Res 23, 1005–1010 (1998). https://doi.org/10.1023/A:1021092624046
Issue Date:
DOI: https://doi.org/10.1023/A:1021092624046